IL94549A - A pharmaceutical preparation containing glutamine - Google Patents

A pharmaceutical preparation containing glutamine

Info

Publication number
IL94549A
IL94549A IL9454990A IL9454990A IL94549A IL 94549 A IL94549 A IL 94549A IL 9454990 A IL9454990 A IL 9454990A IL 9454990 A IL9454990 A IL 9454990A IL 94549 A IL94549 A IL 94549A
Authority
IL
Israel
Prior art keywords
gln
nitrogen
animals
amino acid
bcaa
Prior art date
Application number
IL9454990A
Other languages
English (en)
Hebrew (he)
Other versions
IL94549A0 (en
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23419606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL94549(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Publication of IL94549A0 publication Critical patent/IL94549A0/xx
Publication of IL94549A publication Critical patent/IL94549A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Seasonings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Looms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Packaging Of Machine Parts And Wound Products (AREA)
  • Compounds Of Unknown Constitution (AREA)
IL9454990A 1989-06-02 1990-05-29 A pharmaceutical preparation containing glutamine IL94549A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36083989A 1989-06-02 1989-06-02

Publications (2)

Publication Number Publication Date
IL94549A0 IL94549A0 (en) 1991-03-10
IL94549A true IL94549A (en) 1996-08-04

Family

ID=23419606

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9454990A IL94549A (en) 1989-06-02 1990-05-29 A pharmaceutical preparation containing glutamine

Country Status (16)

Country Link
EP (1) EP0401056B2 (es)
JP (4) JP3068644B2 (es)
KR (1) KR0178799B1 (es)
AT (1) ATE160089T1 (es)
AU (1) AU641403B2 (es)
DE (1) DE69031694T3 (es)
DK (1) DK0401056T4 (es)
ES (1) ES2111529T5 (es)
FI (1) FI915677A0 (es)
GR (1) GR3025678T3 (es)
HU (1) HU220214B (es)
IL (1) IL94549A (es)
NO (1) NO914730D0 (es)
PT (1) PT94223B (es)
WO (1) WO1990014823A1 (es)
ZA (1) ZA904151B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JPH0569836U (ja) * 1992-02-25 1993-09-21 松下電工株式会社 ピアノハンドル式スイッチ
US5438075A (en) 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
EP0738146B1 (en) 1994-01-11 2003-05-02 N.V. Nutricia Method of treating disorders of the animal or human body by administering amino acids
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
JP5473190B2 (ja) * 2003-10-16 2014-04-16 ネステク ソシエテ アノニム 化学療法又は放射線療法の副作用に対する栄養組成物
US8633192B2 (en) 2006-12-15 2014-01-21 Tima Foundation Compositions and uses thereof
CA2673054C (en) * 2006-12-15 2016-05-10 Tima Foundation Novel compositions and uses thereof
EP2612560A1 (en) 2012-01-09 2013-07-10 N.V. Nutricia Glutamine enriched nutritional composition for preterm infants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction

Also Published As

Publication number Publication date
HUT61193A (en) 1992-12-28
ES2111529T5 (es) 2007-11-16
EP0401056A3 (en) 1991-09-25
JP2000198733A (ja) 2000-07-18
EP0401056B2 (en) 2007-06-13
DK0401056T4 (da) 2007-07-16
EP0401056B1 (en) 1997-11-12
JP3113876B2 (ja) 2000-12-04
GR3025678T3 (en) 1998-03-31
JP2000186034A (ja) 2000-07-04
NO914730D0 (no) 1991-12-02
AU5827190A (en) 1991-01-07
JP3113877B2 (ja) 2000-12-04
JPH05500655A (ja) 1993-02-12
HU220214B (hu) 2001-11-28
DE69031694T2 (de) 1998-03-12
EP0401056A2 (en) 1990-12-05
JP3068644B2 (ja) 2000-07-24
PT94223B (pt) 1997-04-30
DE69031694D1 (de) 1997-12-18
JP3113878B2 (ja) 2000-12-04
KR920700629A (ko) 1992-08-10
WO1990014823A1 (en) 1990-12-13
IL94549A0 (en) 1991-03-10
ZA904151B (en) 1991-03-27
ES2111529T3 (es) 1998-03-16
ATE160089T1 (de) 1997-11-15
FI915677A0 (fi) 1991-12-02
DE69031694T3 (de) 2007-10-18
KR0178799B1 (ko) 1999-03-20
DK0401056T3 (da) 1998-07-27
JP2000186035A (ja) 2000-07-04
AU641403B2 (en) 1993-09-23
PT94223A (pt) 1991-02-08

Similar Documents

Publication Publication Date Title
US5039704A (en) Method of treating catabolic dysfunction
US5607975A (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
US5397803A (en) Use of glutamine to reduce rate of pathogenic microorganism infection
JP5612030B2 (ja) オルニチンならびにフェニルアセテートまたはフェニルブチレートを含む、肝性脳症を治療するための組成物
CA1285491C (en) Method of treating catabolic dysfunction
Lara et al. Effect of critical illness and nutritional support on mucosalmass and function
AU641403B2 (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
Boelens et al. Plasma taurine concentrations increase after enteral glutamine supplementation in trauma patients and stressed rats
Nightingale The short-bowel syndrome
JP2011225609A (ja) 栄養失調及び高血漿グルコース状態を治療するためのアルファ−ケトグルタル酸の使用
US5292722A (en) Intravenous solution that diminishes body protein loss
Nightingale Clinical problems of a short bowel and their treatment
Diaz et al. Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients
US5763485A (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
CA2057055C (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
Zilling et al. Nutritional state, growth rate, and morphology after total gastrectomy with restoration of duodenal passage or Roux‐en‐Y oesophagojejunostomy with or without a pouch: an experimental study in pigs
JP2007529408A (ja) 栄養失調及び高血漿グルコース状態を治療するためのアルファ−ケトグルタル酸の使用
Astre et al. Plasma and jejunal glutamine levels after extensive small bowel resection in dogs
MacDonald et al. The Long‐Term Management of Cystinuria
PARKINSON et al. SHORT SMALL‐BOWEL SYNDROME
JP2007022978A (ja) がん自然転移抑制剤
Goulet et al. Parenteral nutrition in infants and children
Okanottc 70 Hemodynamic effects of temporary hepatic arterial and portal occlusion In degradable starch microsphcres M. Andcrsson.! l-. kclwid, M. Ih'lvind. L. Jonsson,!.. Doinelldl
Dinesh Arginine and small intestinal atrophy in parenterally-fed neonatal piglets

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed